The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 10, 2019

Filed:

Apr. 14, 2016
Applicant:

Bristol-myers Squibb Company, Princeton, NJ (US);

Inventors:

Mark R. Krystal, Wallingford, CT (US);

David L. Wensel, Waltham, MA (US);

Jonathan Davis, Waltham, MA (US);

Assignee:

VIIV HEALTHCARE UK (NO.5) LIMITED, Brentford, Middlesex, GB;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61P 31/18 (2006.01); C07K 14/78 (2006.01); A61K 47/60 (2017.01); C07K 14/79 (2006.01); C07K 14/005 (2006.01); C07K 14/765 (2006.01);
U.S. Cl.
CPC ...
C07K 14/78 (2013.01); A61K 47/60 (2017.08); A61P 31/18 (2018.01); C07K 14/005 (2013.01); C07K 14/765 (2013.01); C07K 14/79 (2013.01); A61K 38/00 (2013.01); C07K 2319/00 (2013.01); C07K 2319/30 (2013.01); C07K 2319/31 (2013.01); C12N 2740/16122 (2013.01);
Abstract

The invention is directed to polypeptides comprising a CD4 binding moiety, a gp41 binding moiety, a HIV fusion peptide inhibitor moiety and combinations thereof. More specifically, the present invention relates to polypeptides comprising a fibronectin-based scaffold domain protein that binds CD4, a fibronectin-based scaffold domain protein that binds the N17 domain of gp41, and a HIV fusion peptide inhibitor or combinations thereof. The invention also relates to the use of the innovative proteins in therapeutic applications to treat HIV.


Find Patent Forward Citations

Loading…